https://wikimd.org/index.php?action=history&feed=atom&title=Sacubitrilat 2026-04-27T10:04:32Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Sacubitrilat&diff=6336537&oldid=prev 2025-02-20T01:48:47Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:48, 20 February 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l31">Line 31:</td> <td colspan="2" class="diff-lineno">Line 31:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;gallery&gt;</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:Sacubitrilat skeletal.svg|Sacubitrilat</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;/gallery&gt;</ins></div></td></tr> </table>

Prab https://wikimd.org/index.php?title=Sacubitrilat&diff=5375193&oldid=prev 2024-03-08T18:56:12Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Sacubitrilat&#039;&#039;&#039; is the active metabolite of [[sacubitril]], a prodrug that is used in combination with [[valsartan]] to treat [[heart failure]]. Sacubitrilat is a [[neprilysin]] inhibitor, which means it blocks the action of an enzyme that breaks down certain peptides in the body. By inhibiting this enzyme, sacubitrilat increases the levels of these peptides, which can have beneficial effects on the cardiovascular system.<br /> <br /> ==Pharmacology==<br /> <br /> Sacubitril is converted to sacubitrilat in the body by a process known as [[hydrolysis]]. This conversion is carried out by an enzyme called [[esterase]]. Once sacubitrilat is formed, it inhibits the enzyme neprilysin. Neprilysin is responsible for breaking down certain peptides, including [[natriuretic peptides]], which are involved in regulating blood volume and blood pressure.<br /> <br /> By inhibiting neprilysin, sacubitrilat increases the levels of natriuretic peptides. This leads to a number of effects, including dilation of the blood vessels, increased urine output, and decreased release of [[aldosterone]]. These effects can help to reduce the symptoms of heart failure.<br /> <br /> ==Clinical Use==<br /> <br /> Sacubitril, in combination with valsartan, is used to treat heart failure. This combination is often used in patients who have not responded adequately to other treatments for heart failure. The combination of sacubitril and valsartan has been shown to reduce the risk of hospitalization and death in patients with heart failure.<br /> <br /> ==Side Effects==<br /> <br /> The most common side effects of sacubitril/valsartan are low blood pressure, high potassium levels, and kidney problems. Other side effects can include dizziness, cough, and swelling of the face, lips, tongue, or throat.<br /> <br /> ==See Also==<br /> <br /> * [[Heart failure]]<br /> * [[Valsartan]]<br /> * [[Neprilysin]]<br /> * [[Natriuretic peptides]]<br /> <br /> ==References==<br /> <br /> {{reflist}}<br /> <br /> [[Category:Pharmacology]]<br /> [[Category:Cardiology]]<br /> [[Category:Medicine]]<br /> <br /> {{pharmacology-stub}}</div>

Prab